Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The ...

Allworth Financial LP boosted its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 12.9% in the fourth quarter, ...

Purchase price represents enterprise value of $85 million plus FibroGen net cash held in China at closing, currently ...

Dubai: A new executive committee has taken charge at the Pharmaceutical Research and Manufacturers Association Gulf for the ...

AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...

AstraZeneca PLC ADR closed 14.96% below its 52-week high of $87.68, which the company achieved on August 30th.

Purchase price represents enterprise value of $85 million plus FibroGen net cash held in China at closing, currently estimated to be ...

The global biotechnology market was worth USD 1.68 trillion in 2024 and is expected to surge around USD 3.54 Trillion by 2033, with a noteworthy CAGR of 9.18% from 2024 to 2033. The growing demand for ...

AstraZeneca may have exited the COVID-19 vaccine market, but it is still hoping to protect vulnerable patients with its antibody sipavibart for pre-exposure prophylaxis (PrEP). The drugmaker said ...